title: What's new in the management of chronic primary immune thrombocytopenia in adults and the use of thrombopoietin receptor agonists.
authors.affiliation: Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Turner Street, London, UK. a.c.newland@qmul.ac.uk
authors.forename: Adrian
authors.initials: A
authors.lastname: Newland
mesh_terms: D002908:Chronic Disease; D006801:Humans; D010976:Platelet Count; D011092:Polyethylene Glycols / Q000627:therapeutic use; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D053628:Receptors, Thrombopoietin / Q000819:agonists* / Q000378:metabolism; D011994:Recombinant Proteins / Q000627:therapeutic use; D012307:Risk Factors; D013156:Splenectomy; D013926:Thrombopoietin / Q000627:therapeutic use; D017211:Treatment Failure
chemical_list: D053628:Receptors, Thrombopoietin; D011994:Recombinant Proteins; C103117:polyethylene glycol-recombinant human megakaryocyte growth and development factor; D011092:Polyethylene Glycols; D013926:Thrombopoietin